Clinical Trial

CEDUR - German IBD Registry

Study acronym: CEDUR
Recruiting
View on ClinicalTrials.gov →
Summary
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Trial Details
NCT Number NCT07319442
Lead Sponsor ImmunoRegister gUG
Conditions Ulcerative Colitis (UC), Indeterminate Colitis, Crohn Disease (CD)
Enrollment 10,000 participants
Start Date 2018-05-03
Primary Completion 2036-05 (estimated)
Study Completion 2036-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-06